Related Experiment Video
Updated: Feb 17, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Clinical outcome of cardioembolic stroke treated by intravenous thrombolysis
D Vaclavik1, A Vilionskis2, D Jatuzis3
1Department of Neurology, Ostrava Vitkovice Hospital, Agel Research and Training Institute, Ostrava, Czech Republic.
Insights
Cardioembolic stroke (CS) patients treated with intravenous thrombolysis (IVT) do not face increased mortality. These patients show reduced risk of symptomatic intracranial hemorrhage and better outcomes post-IVT compared to other stroke types.
Area of Science:
- Neurology
- Cardiology
- Stroke Medicine
Background:
- Cardioembolic stroke (CS) historically presents worse outcomes and higher mortality without thrombolytic treatment compared to other stroke types.
- Intravenous thrombolysis (IVT) is a critical treatment for acute ischemic stroke.
- Understanding the specific outcomes of CS patients undergoing IVT is crucial for optimizing treatment strategies.
Purpose of the Study:
- To evaluate the clinical outcomes of patients with cardioembolic stroke (CS) who received intravenous thrombolysis (IVT).
- To compare the outcomes of CS patients with other stroke etiologies treated with IVT.
Main Methods:
- Analysis of data from the SITS-EAST register (2000-2014) for patients receiving IVT.
- Categorization of stroke etiology using ICD-10 classification.
- Assessment of outcomes including excellent clinical outcome (mRS 0-1 at 3 months), symptomatic intracranial hemorrhage (sICH), mortality, and early improvement (24 hours).
- Univariate and multivariate analyses were employed to determine the effect of stroke etiology on outcomes.
Main Results:
- A total of 13,772 patients were analyzed, with CS accounting for 30% of all strokes.
- CS patients were older (mean age 70.8 years) and presented with more severe strokes (median NIHSS 13) compared to other etiologies.
- No significant difference in mortality was observed between CS and atherothrombotic stroke.
- CS patients demonstrated lower odds of symptomatic intracranial hemorrhage (sICH) and higher odds of early improvement and excellent clinical outcome after IVT compared to atherothrombotic stroke.
Conclusions:
- Cardioembolic strokes (CS) treated with intravenous thrombolysis (IVT) are not associated with increased mortality.
- Patients experiencing CS treated with IVT have a reduced likelihood of symptomatic intracranial hemorrhage (sICH).
- CS patients treated with IVT generally experience better clinical outcomes compared to other stroke types.
Introduction:
Cardioembolic stroke (CS) in patients without thrombolytic treatment is associated with a worse clinical outcome and higher mortality compared to other types of stroke. The aim of this study was to determine the clinical outcome of CS in patients treated by intravenous thrombolysis (IVT).
Material And Methodology:
Data of patients from the SITS-EAST register (Safe Implementation of Treatments in Stroke) were analyzed in patients who received IVT treatment from 2000 to April 2014. The effect of the stroke etiology according to ICD-10 classification on outcome was analyzed using a univariate and multivariate analysis. The outcomes were assessed as follows: excellent clinical outcome (modified Rankin scale (mRS) 0-1) at 3 months, the rate of symptomatic intracranial hemorrhage (sICH), mortality, and improvement at 24 hours after IVT.
Results:
Data of 13 772 patients were analyzed. CS represented 30% of all strokes. The mean age of patients with CS, atherothrombotic stroke, lacunar stroke, and other stroke was 70.8, 66.7, 66.2, and 63.3 years, respectively (P < .001). Severity of stroke on admission by median NIHSS score was 13 points in patients with CS, 12 points - in atherothrombotic stroke, 7 points - in lacunar stroke, and 10 points-in other stroke types (P < .001). No difference in mortality was detected among atherothrombotic and CS; however, atherothrombotic strokes had higher odds of sICH [OR = 1.63 (95% CI: 1.07-2.47), P = .023], lower odds of early improvement [OR = 0.79 (95% CI: 0.72-0.86), P < .001], and excellent clinical outcome [OR = 0.77 (95% CI: 0.67-0.87), P < .001] compared with CS.
Conclusions:
Cardioembolic strokes are not associated with increased mortality. Patients with CS are less likely to have sICH and have better outcome after IVT.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pulmonary Embolism III: Nursing Management
Venous Thrombosis IV: Nursing Management
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Acute Coronary Syndrome IV: Interprofessional Care

